Our mission is to develop disease-modifying therapies to stop or reverse the progression of neurodegenerative diseases to address the unmet medical need.
-
Highlight
Watch Herantis Pharma’s Full Year 2023 webcast here
-
Highlight
Herantis Pharma announces positive topline data from the Phase 1a clinical trial of HER-096